CABA (STOCKS)
Cabaletta Bio, Inc. Common Stock
$3.209900
+0.079900 (+2.55%)
Prev close: $3.130000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Steven Nichtberger
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $356.79M
- Employees
- 167
- P/E (TTM)
- -1.40
- P/B (TTM)
- 2.81
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
6
Strong Buy
7
Buy
3
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Dec 2025 (Q4)
|
$-0.40 | $-0.47 | +0.0741 | +15.63% |
|
Sep 2025 (Q3)
|
$-0.44 | $-0.48 | +0.0414 | +8.60% |
|
Jun 2025 (Q2)
|
$-0.73 | $-0.66 | -0.0673 | -10.16% |
|
Mar 2025 (Q1)
|
$-0.71 | $-0.67 | -0.0425 | -6.37% |
Financial Statements
| Revenues | $0.00 |
| Operating Expenses | $172.24M |
| Research and Development | $142.67M |
| Other Operating Expenses | $29.57M |
| Operating Income/Loss | -$172.24M |
| Income/Loss From Continuing Operations After Tax | -$167.86M |
| Income/Loss From Continuing Operations Before Tax | -$167.86M |
| Income Tax Expense/Benefit | $0.00 |
| Interest Expense, Operating | $2.00M |
| Net Income/Loss | -$167.86M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$167.86M |
| Net Income/Loss Available To Common Stockholders, Basic | -$167.86M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$2.10 |
| Diluted Earnings Per Share | -$2.10 |
| Assets | $165.08M |
| Current Assets | $138.87M |
| Cash | $133.60M |
| Other Current Assets | $5.27M |
| Noncurrent Assets | $26.21M |
| Fixed Assets | $1.92M |
| Other Non-current Assets | $24.29M |
| Liabilities | $53.03M |
| Current Liabilities | $50.15M |
| Accounts Payable | $6.64M |
| Wages | $9.72M |
| Other Current Liabilities | $33.80M |
| Noncurrent Liabilities | $2.88M |
| Equity | $112.05M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $112.05M |
| Liabilities And Equity | $165.08M |
| Net Cash Flow From Operating Activities | -$131.08M |
| Net Cash Flow From Operating Activities, Continuing | -$131.08M |
| Net Cash Flow From Investing Activities | -$50.27M |
| Net Cash Flow From Investing Activities, Continuing | -$50.27M |
| Net Cash Flow From Financing Activities | $100.35M |
| Net Cash Flow From Financing Activities, Continuing | $100.35M |
| Exchange Gains/Losses | $19.00K |
| Net Cash Flow | -$80.98M |
| Net Cash Flow, Continuing | -$81.00M |
| Comprehensive Income/Loss | -$167.83M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$167.83M |
| Other Comprehensive Income/Loss | $25.00K |